Everest Medicines departing CEO Kerry Blanchard (L) and Everest president and CFO Ian Woo

Af­ter Chi­na Trodelvy OK, Ever­est Med­i­cines CEO re­signs and the hunt is on for his re­place­ment

Shang­hai-based Ever­est Med­i­cines CEO has hit the com­pa­ny’s ex­it door.

Ker­ry Blan­chard has re­signed as the CEO and as a mem­ber of the board of di­rec­tors, ef­fec­tive im­me­di­ate­ly, Ever­est an­nounced Fri­day. Af­ter spend­ing near­ly 17 years at Eli Lil­ly where he rose to the rank of VP, Blan­chard spent three years as a top ex­ec­u­tive for oth­er phar­ma com­pa­nies in Chi­na, in­clud­ing a year-long stint at In­novent Bi­o­log­ics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.